Clinical Trial

Acute and Long-Term Antidepressant Treatment Success in Adolescents With Anxiety (AtLAS-A)

Study acronym: AtLAS-A
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2024 (before its estimated July 2025 completion). Its status may not reflect the trial's current state.
Summary
Acute, double-blind, adaptively randomized treatment with duloxetine or escitalopram, followed by open-label naturalistic follow-up.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2020-01-27; most recent amendment 2024-08-28.
Status change: Not Yet Recruiting → Recruiting 2020-07-22
Trial Details
NCT Number NCT04245436
Lead Sponsor University of Cincinnati
Conditions Anxiety, Depressive Symptoms
Enrollment 60 participants
Start Date 2020-01-01
Primary Completion 2025-07 (estimated)
Study Completion 2025-08 (estimated)
Updated on ClinicalTrials.gov 2024-08-29